Streetbeat News

Products Services

CYCC

GMM

MMM

3M shares surged 8.3% after a Q1 earnings beat. Cyclacel Pharmaceuticals soared 103% following the withdrawal of its Form S-1 registration and announcing an $8 million private placement. Global Mofy Metaverse (GMM) jumped 62% as it collaborates with Heartdub to use NVIDIA Omniverse for developing the GAUSSPEED Generative Video AI Platform.

Portfolio Pulse from ryanfaloona@benzinga.com

April 30, 2024 | 12:45 pm

MAMO

Massimo Group (NASDAQ:MAMO) has announced a distribution partnership with Fleet Farm to sell its UTV, ATV, and youth series product lines in stores and online. This partnership aims to leverage Fleet Farm's strong Midwest presence and Massimo's diverse range of powersports vehicles to meet the growing demand for UTVs and ATVs in the U.S. The agreement includes six Massimo products, highlighting the company's commitment to expanding its distribution network and capitalizing on the increasing outdoor activity trend.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:44 pm

CLIR

ClearSign Technologies Corporation (NASDAQ:CLIR) has received two purchase orders for the engineering of burners for two additional heaters at a California refinery, following the successful installation and startup of burners for two other heaters earlier this year. These orders, for which no financial terms were disclosed, are part of an ongoing relationship with the refinery, highlighting the refinery's commitment to meeting and exceeding California's clean air goals with ClearSign's technology.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:43 pm

BYDDF

BYDDY

BYD Co Ltd is recalling 16,666 Seagull EVs due to faulty reversing cameras caused by software issues in vehicles produced between April 7, 2023, and May 31, 2023. The company plans to address the problem with an over-the-air software upgrade, and for vehicles that cannot be fixed remotely, BYD will contact customers for a direct software upgrade. This recall comes as BYD maintains its position as the top EV maker in China, with a 13.44% increase in sales of new energy vehicles in the first quarter of 2024.

Portfolio Pulse from Anan Ashraf

April 30, 2024 | 12:42 pm

WVE

Wave Life Sciences Ltd. (NASDAQ:WVE) announced the approval of its first clinical trial application for the RestorAATion-2 trial of WVE-006, aimed at treating alpha-1 antitrypsin deficiency (AATD). WVE-006, a first-in-class RNA editing oligonucleotide, does not use a lipid nanoparticle delivery system and is subcutaneously administered. The trial will evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of WVE-006 in individuals with AATD. GSK holds the exclusive global license for WVE-006, with development and commercialization responsibilities transferring to GSK after the completion of the RestorAATion-2 study. Wave Life Sciences is also advancing its RNA editing pipeline across various targets.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:40 pm

ADEA

Adeia Inc. (NASDAQ:ADEA) has signed a long-term intellectual property (IP) license agreement with Astound Broadband to license Adeia's media IP portfolio. This partnership aims to enhance digital entertainment experiences for Astound's customers by leveraging Adeia's patented technologies. The agreement reflects both companies' commitment to innovation in the digital TV, high-speed internet, and phone services sectors, amidst changing national demand and consumer preferences.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:39 pm

NRXP

NRx Pharmaceuticals announced that both NRX-101 and lurasidone, a standard treatment for Bipolar Depression, showed a roughly 50% reduction in depression symptoms. This positions NRX-101 as a potentially significant treatment option alongside established medications.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:38 pm

GROM

Grom Social Enterprises, Inc. (NASDAQ:GROM) is advancing towards the acquisition of Arctic7, a Texas-based gaming industry service provider. The companies are now in the definitive documents draft phase of the deal, initially announced in March. This acquisition aims to integrate Arctic7's gaming development services with Grom's family-friendly media and technology solutions, potentially tapping into the $180B gaming industry. Arctic7 is expected to operate as a division within Grom post-acquisition, focusing on delivering engaging gaming experiences.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:38 pm

SSKN

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) announced the placement of six XTRAC devices with dermatology clinics in Q1 of 2024, marking significant 'comebacks' from clinics that had previously left but have now rejoined STRATA's partner program. These include notable clinics like Henry Ford Health System, Integrated Dermatology Group, and Schweiger Dermatology Group. This move is seen as a validation of STRATA's partner program and is part of a broader strategy to increase device utilization and average revenue per device through direct-to-consumer marketing and efforts to regain lapsed customers.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:35 pm

CDXC

ChromaDex has entered into an ingredient partnership with Solgar to feature NIAGEN in Solgar's new product, Cellular Nutrition Cellular Energy, aimed at supporting NAD+ levels for cellular health.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:35 pm